ConductScience.org, home

Paper36765741

Targeting Class I-II-III PI3Ks in Cancer Therapy: Recent Advances in Tumor Biology and Preclinical Research.

Thibault B and 2 others. Cancers (Basel), 2023. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Targeting Class I-II-III PI3Ks in Cancer Therapy: Recent Advances in Tumor Biology and Preclinical Research. Papers, record 36765741. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36765741

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting Class I-II-III PI3Ks in Cancer Therapy: Recent Advances in Tumor Biology and Preclinical Research.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
2.97
iCite
Revised in PubMed
2023-02-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thibault BBenoîthttps://orcid.org/0000-0003-3250-1988
2Ramos-Delgado FFernandahttps://orcid.org/0000-0002-6859-4381
3Guillermet-Guibert JJuliehttps://orcid.org/0000-0003-3173-4907

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Toucan, Projet-ANR-18-CE14-0013Agence Nationale de la RecherchePubMed
Project ID: 675392MSCA-ITN/ETN PhD-PI3KPubMed

Source PubMed

Download CSV of grants

References145

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128390196PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines.Oncotarget2017https://conductscience.org/library/papers/28390196PubMed
217644513The role of phosphoinositide 3-kinase C2alpha in insulin signaling.J Biol Chem2007https://conductscience.org/library/papers/17644513PubMed
333740047Organismal roles for the PI3Kα and β isoforms: their specificity, redundancy or cooperation is context-dependent.Biochem J2021https://conductscience.org/library/papers/33740047PubMed
426132308Novel Role for p110β PI 3-Kinase in Male Fertility through Regulation of Androgen Receptor Activity in Sertoli Cells.PLoS Genet2015https://conductscience.org/library/papers/26132308PubMed
527270320PIK3C2A mRNA functions as a miR-124 sponge to facilitate CD151 expression and enhance malignancy of hepatocellular carcinoma cells.Oncotarget2016https://conductscience.org/library/papers/27270320PubMed
620876794Key role of phosphoinositide 3-kinase class IB in pancreatic cancer.Clin Cancer Res2010https://conductscience.org/library/papers/20876794PubMed
730055290Targeting autophagy by small molecule inhibitors of vacuolar protein sorting 34 (Vps34) improves the sensitivity of breast cancer cells to Sunitinib.Cancer Lett2018https://conductscience.org/library/papers/30055290PubMed
828800863Targeting PI3K/AKT pathway in triple-negative breast cancer.Lancet Oncol2017https://conductscience.org/library/papers/28800863PubMed
927697050Hybrid Compounds as Multitarget Directed Anticancer Agents.Curr Top Med Chem2017https://conductscience.org/library/papers/27697050PubMed
1033880878PI3KC2β inactivation stabilizes VE-cadherin junctions and preserves vascular integrity.EMBO Rep2021https://conductscience.org/library/papers/33880878PubMed
1126934321Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression.Oncotarget2016https://conductscience.org/library/papers/26934321PubMed
1234544753RTK-Dependent Inducible Degradation of Mutant PI3Kα Drives GDC-0077 (Inavolisib) Efficacy.Cancer Discov2022https://conductscience.org/library/papers/34544753PubMed
1318544649The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18544649PubMed
1429233821Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma.Blood2018https://conductscience.org/library/papers/29233821PubMed
1522983395Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function.Nat Med2012https://conductscience.org/library/papers/22983395PubMed
1626073258miR-362-5p inhibits proliferation and migration of neuroblastoma cells by targeting phosphatidylinositol 3-kinase-C2β.FEBS Lett2015https://conductscience.org/library/papers/26073258PubMed
1726342236
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Lancet Oncol2015https://conductscience.org/library/papers/26342236PubMed
1831911549Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features.Cancer Res2020https://conductscience.org/library/papers/31911549PubMed
1926983806Novel roles for class II Phosphoinositide 3-Kinase C2β in signalling pathways involved in prostate cancer cell invasion.Sci Rep2016https://conductscience.org/library/papers/26983806PubMed
2022696681Phosphatidylinositol 3,5-bisphosphate plays a role in the activation and subcellular localization of mechanistic target of rapamycin 1.Mol Biol Cell2012https://conductscience.org/library/papers/22696681PubMed

See all 145 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42515723Overcoming Resistance to Anti-EGFR Therapies: Mechanisms of Cetuximab and Panitumumab Resistance and Emerging Combination Strategies.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42515723PubMed
42446738PIK3CA mutations and PI3K isoform expression define prognostic signatures in ovarian clear cell carcinoma.Arch Gynecol Obstet2026https://conductscience.org/library/papers/42446738PubMed
41972724VPS34 in Autophagy, Cancer, and Cancer Therapy.Cells2026https://conductscience.org/library/papers/41972724PubMed
41754938Smart Nanoformulations for Oncology: A Review on Overcoming Biological Barriers with Active Targeting, Stimuli-Responsive, and Controlled Release for Effective Drug Delivery.Pharmaceutics2026https://conductscience.org/library/papers/41754938PubMed
41686813PIKI-1, a class II PI 3-kinase, functions in endocytic trafficking.PLoS Genet2026https://conductscience.org/library/papers/41686813PubMed
41422162Integrative analysis of scRNA-seq and RNA-seq to investigate the prognostic value of lactylation and fibroblast-related genes in intrahepatic cholangiocarcinoma.Sci Rep2025https://conductscience.org/library/papers/41422162PubMed
41049266Breast Cancer: Molecular Pathogenesis and Targeted Therapy.MedComm (2020)2025https://conductscience.org/library/papers/41049266PubMed
40830981The role of the striatin family proteins in hippo signaling and cellular regulation.Cell Biosci2025https://conductscience.org/library/papers/40830981PubMed
40475523PIKI-1, a class II phosphatidylinositol 3-kinase, functions in endocytic trafficking.bioRxiv2025https://conductscience.org/library/papers/40475523PubMed
40427108PI3Kδ as a Novel Therapeutic Target for Aggressive Prostate Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/40427108PubMed
40027467A narrative review of autophagy in migraine.Front Neurosci2025https://conductscience.org/library/papers/40027467PubMed
39944823The role of ubiquitination and deubiquitination in cancer lipid metabolism.Front Oncol2025https://conductscience.org/library/papers/39944823PubMed
39821606Class III Phosphatidylinositol-3 Kinase/Vacuolar Protein Sorting 34 in Cardiovascular Health and Disease.J Cardiovasc Transl Res2025https://conductscience.org/library/papers/39821606PubMed
39534586Regulation of PI3K signaling in cancer metabolism and PI3K-targeting therapy.Transl Breast Cancer Res2024https://conductscience.org/library/papers/39534586PubMed
39457034In Silico Discovery of a Novel PI3Kδ Inhibitor Incorporating 3,5,7-Trihydroxychroman-4-one Targeting Diffuse Large B-Cell Lymphoma.Int J Mol Sci2024https://conductscience.org/library/papers/39457034PubMed
39337387O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer.Int J Mol Sci2024https://conductscience.org/library/papers/39337387PubMed
39161590The essential roles of lncRNAs/PI3K/AKT axis in gastrointestinal tumors.Front Cell Dev Biol2024https://conductscience.org/library/papers/39161590PubMed
39127670Targeting PI3K family with small-molecule inhibitors in cancer therapy: current clinical status and future directions.Mol Cancer2024https://conductscience.org/library/papers/39127670PubMed
38396649Molecular Targeting of the Phosphoinositide-3-Protein Kinase (PI3K) Pathway across Various Cancers.Int J Mol Sci2024https://conductscience.org/library/papers/38396649PubMed
38332727Discoidin domain receptor 2 signaling through PIK3C2α in fibroblasts promotes lung fibrosis.J Pathol2024https://conductscience.org/library/papers/38332727PubMed

See all 21 cited byDownload CSV of cited by

Genes34

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
BCR613PubTator's text mininghttps://conductscience.org/library/genes/613NCBI Gene
CANT1124583PubTator's text mininghttps://conductscience.org/library/genes/124583NCBI Gene
CCNB1891PubTator's text mininghttps://conductscience.org/library/genes/891NCBI Gene
COL11A21302PubTator's text mininghttps://conductscience.org/library/genes/1302NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
IGF1R3480PubTator's text mininghttps://conductscience.org/library/genes/3480NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
KRT2054474PubTator's text mininghttps://conductscience.org/library/genes/54474NCBI Gene
MAP1LC3A84557PubTator's text mininghttps://conductscience.org/library/genes/84557NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene
NUP6223636PubTator's text mininghttps://conductscience.org/library/genes/23636NCBI Gene
PDK15163PubTator's text mininghttps://conductscience.org/library/genes/5163NCBI Gene
PIK3C2A5286PubTator's text mininghttps://conductscience.org/library/genes/5286NCBI Gene
PIK3C2B5287PubTator's text mininghttps://conductscience.org/library/genes/5287NCBI Gene
PIK3C2G5288PubTator's text mininghttps://conductscience.org/library/genes/5288NCBI Gene
PIK3C35289PubTator's text mininghttps://conductscience.org/library/genes/5289NCBI Gene

See all 34 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36765741

GET https://conductscience.org/api/papers/v1/36765741/references?page=2